Lyra Therapeutics Inc Forecast, price target & analysts
Lyra Therapeutics Inc Target price 2026 - Analyst rating & recommendation
Lyra Therapeutics Inc Classifications & Recommendation
Lyra Therapeutics Inc Price Target
| Target Price | $16.32 |
| Price | $0.03 |
| Potential |
54,300.00%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Lyra Therapeutics Inc 2027 .
The average Lyra Therapeutics Inc target price is $16.32.
This is
54,300.00%
register free of charge
$16.80
55,900.00%
register free of charge
$16.16
53,766.67%
register free of charge
|
|
| A rating was issued by 6 analysts: 0 Analysts recommend Lyra Therapeutics Inc to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Lyra Therapeutics Inc stock has an average upside potential 2027 of
54,300.00%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.40 | 0.71 |
| 73.86% | 78.50% | |
| Net Margin | -7,230.00% | -1,775.06% |
| 18.39% | 75.45% |
3 Analysts have issued a sales forecast Lyra Therapeutics Inc 2026 . The average Lyra Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
3 Lyra Therapeutics Inc Analysts have issued a net profit forecast 2026. The average Lyra Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -18.62 | -7.16 |
| 74.05% | 61.55% | |
| P/E | 0.00 | |
| EV/Sales | negative |
3 Analysts have issued a Lyra Therapeutics Inc forecast for earnings per share. The average Lyra Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
P/E ratio
| Current | 0.00 | 99.20% |
|---|---|---|
| 2026 |
0.00
100.00%
unlock
|
|
Lyra Therapeutics Inc...
Current Lyra Therapeutics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 14 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 14 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 14 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
